Oral antiseptic composition useful for treating oral mucositis

A method for the treatment of mucositis or stomatitis, particularly associated with an anticancer therapy, comprising the steps of:

• a. providing an oral pharmaceutical composition in the form of an oral topical solution comprising:
• i. at least one antiseptic agent selected from the group consisting of:
• A) hydrogen peroxide and carbamide peroxide, and a mixture thereof, in an amount from 0.001% to 1% w/w composition,
• B) cetylpyridinium chloride, in an amount from 0.005% to 5% w/w composition, and
• C) a mixture thereof;
• ii. an essential oil consisting of eugenol, in an amount from 0.005% to 0.04% w/w composition;
• iii. a phenolic antiseptic agent consisting of para-chlorophenol, in an amount from 0.001% to 0.01% w/w composition;
• iv. an agent with anti-inflammatory properties consisting of camphor in an amount of from 0.006% to 0.05% w/w composition;
• v. a flavoring agent selected from the group consisting of menthol, methyl acetate, methyl lactate, camphor, eucalyptus oil, eucalyptol, and oxanone, and a mixture thereof, in an amount from 0.01% to 5% w/w composition;
• vi. a plant extract consisting of chamomile, in an amount from 0.05% to 0.5% w/w composition;
• vii. a sweetening agent selected from the group consisting of sucralose, xylitol and a mixture thereof in an amount of 0.01% to 15% w/w composition;
• and
• viii. a pharmaceutically acceptable excipient selected from the group consisting of glycerin, sorbitol and a glycol, in an amount from 0.05% to 0.5% w/w composition;
• and
• b. applying the oral pharmaceutical composition in the oral cavity of a patient having oral mucositis or stomatitis associated with an anticancer therapy, at least five times a day.